Research

The Harold Schnitzer Diabetes Health Center is committed to promoting research. Our goal is to enhance the quality of life of those living with diabetes.

Our efforts to find a cure for diabetes is made possible by volunteers who participate in research studies. When you volunteer, you help us answer important questions about diabetes.

If you would like to be considered as a potential volunteer for our research studies complete our Online Diabetes Research Application Form or call/email the contact listed below for each study for more information.

Current studies

Would you be interested in trying a new GLP-1 medication similar to Ozempic?

We are seeking volunteers to test a new investigational glucagon-like peptide-1 (GLP-1) medication similar to Mounjaro and Ozempic. However, this GLP-1 will be approved for Type 1 instead of Type 2 diabetics and unlike other GLP-1 medications on the market, the study drug has not been shown to cause skeletal muscle loss. The purpose of this study is to see how safe and tolerable the study drug is and to see if the study drug improves your diabetes management. This category of drugs helps regulate blood sugar, appetite and digestion. If you agree to be in the study, you may be given the study drug or a placebo (a placebo does not contain any active ingredients but looks like the study drug). Your participation in this research study will involve approximately 13 visits to the research center and will last about 25 weeks.

Compensation is $100 for each visit and potential to receive stipends totally $250.

You may be eligible to participate if you are:

  • Diagnosed with type 1 diabetes for at least one year
  • Age 18 to 65 years old
  • Stable insulin dosing/formulation for at least 2 months
  • HbA1c between 7-10%
  • BMI 27 or higher
  • Have not used nicotine products during the last 6 months
  • Have not used in last 6 months any medication that could improve/interfere with glucose control or for weight loss

Oregon Health and Science University | Portland, Oregon
Please contact Deborah Branigan at 503-418-9070
Email: diabetesresearch@ohsu.edu

TINSAL-FISH Study

The 博彩网站 Harold Schnitzer Diabetes Center (PI: Dr. Rodica Busui, MD PhD) is part of a multicenter trial funded by the National Institute of Health to identify new therapies that could reverse diabetic neuropathy, a very common and challenging complication of diabetes that leads to nerve damage and loss. The trial is evaluating whether fish oil, alone and in combination with salsalate, a drug approved to treat arthritis may be effective to treat diabetic peripheral neuropathy, and identify new targets that could be tested in a future trial. This study is being conducted at the University of Iowa, at the University of Michigan, and Oregon Health and Sciences University (博彩网站).

Key Eligibility Criteria:

  • Are 18 years or older
  • Have type 2 diabetes
  • Have an HbA1c at screening less than 9.5%

Duration: About 6 months.

If you are interested or would like more information, please contact the study team at 971-484-5758 or 971-610-3005 or email tinsalfish@ohsu.edu.

博彩网站 IRB# 27479